Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.

by Ann Levin, Susan A Wang, Carol Levin, Vivien Tsu, Raymond Hutubessy
Published 2014-01-01

Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.

by Christian Schaetti, Said M Ali, Claire-Lise Chaignat, Ahmed M Khatib, Raymond Hutubessy, Mitchell G Weiss
Published 2012-01-01

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study

by Mark Jit, PhD, Marc Brisson, PhD, Allison Portnoy, MSPH, Dr. Raymond Hutubessy, PhD
Published 2014-07-01

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study

by Changfa Xia, Xiaoqian Xu, Xuelian Zhao, Shangying Hu, Youlin Qiao, Yong Zhang, Raymond Hutubessy, Partha Basu, Nathalie Broutet, Mark Jit, Fanghui Zhao
Published 2021-03-01

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

by Christian Schaetti, Mitchell G Weiss, Said M Ali, Claire-Lise Chaignat, Ahmed M Khatib, Rita Reyburn, Radboud J Duintjer Tebbens, Raymond Hutubessy
Published 2012-01-01

Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.

by Clint Pecenka, Spy Munthali, Paul Chunga, Ann Levin, Win Morgan, Philipp Lambach, Niranjan Bhat, Kathleen M Neuzil, Justin R Ortiz, Raymond Hutubessy
Published 2017-01-01

Guidelines for multi-model comparisons of the impact of infectious disease interventions

by Saskia den Boon, Mark Jit, Marc Brisson, Graham Medley, Philippe Beutels, Richard White, Stefan Flasche, T. Déirdre Hollingsworth, Tini Garske, Virginia E. Pitzer, Martine Hoogendoorn, Oliver Geffen, Andrew Clark, Jane Kim, Raymond Hutubessy
Published 2019-08-01

Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study

by Changfa Xia, MPH, Shangying Hu, PhD, Xiaoqian Xu, MPH, Xuelian Zhao, MPH, Youlin Qiao, ProfPhD, Nathalie Broutet, PhD, Karen Canfell, ProfDPhil, Raymond Hutubessy, PhD, Fanghui Zhao, ProfPhD
Published 2019-09-01

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

by Siobhan Botwright, Anna-Lea Kahn, Raymond Hutubessy, Patrick Lydon, Joseph Biey, Abdoul Karim Sidibe, Ibrahima Diarra, Mardiati Nadjib, Auliya A. Suwantika, Ery Setiawan, Rachel Archer, Debra Kristensen, Marion Menozzi-Arnaud, Ado Mpia Bwaka, Jason M. Mwenda, Birgitte K. Giersing
Published 2020-12-01

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.

by Ramadhan Hashim, Ahmed M Khatib, Godwin Enwere, Jin Kyung Park, Rita Reyburn, Mohammad Ali, Na Yoon Chang, Deok Ryun Kim, Benedikt Ley, Kamala Thriemer, Anna Lena Lopez, John D Clemens, Jacqueline L Deen, Sunheang Shin, Christian Schaetti, Raymond Hutubessy, Maria Teresa Aguado, Marie Paule Kieny, David Sack, Stephen Obaro, Attiye J Shaame, Said M Ali, Abdul A Saleh, Lorenz von Seidlein, Mohamed S Jiddawi
Published 2012-01-01

Reassessing the value of vaccines

by Till Bärnighausen, Seth Berkley, Zulfiqar A Bhutta, David M Bishai, Maureen M Black, David E Bloom, Dagna Constenla, Julia Driessen, John Edmunds, David Evans, Ulla Griffiths, Peter Hansen, Farah Naz Hashmani, Raymond Hutubessy, Dean T Jamison, Prabhat Jha, Mark Jit, Hope Johnson, Ramanan Laxminarayan, Bruce Y Lee, Sharmila Mhatre, Anne Mills, Anders Nordström, Sachiko Ozawa, Lisa Prosser, Karlee Silver, Christine Stabell Benn, Baudouin Standaert, Damian Walker
Published 2014-05-01